EYE vs LDX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

57MEDIUM

LDX

LUMOS FPO [LDX]

54MEDIUM

Score Breakdown

EYE LDX
Technical
57
35
Catalyst
53
51
Sentiment
50
50
Fundamental
76
76
Momentum
39
36
Risk Gate
45
45

Key Metrics

EYE Metric LDX
$32.8MMarket Cap$84.1M
269KAvg Volume (20d)2.9M
N/AShort InterestN/A
$0.20552-Week High$0.330
$0.10052-Week Low$0.029
+0.0%Daily Change-4.4%
$0.115Reference Price$0.086
-42.4%ROE-123.3%
-21.3%Profit Margin-75.8%

Active Signals

EYE Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Low P/S ratio (1.0x)
Strong revenue growth (+29%)
EPS estimates revised upward (+10pts)

LDX Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Trading below both moving averages — the trend is working against this one
Above-average volume (1.9x) on a red day — sellers in control
Took a hit — down 18.1% over the last 5 days
Lagging the Small Ords index — relative strength of 0.84, underperforming its peers

Ask Scout AI to compare EYE and LDX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs PNV →EYE vs PTX →EYE vs RHT →EYE vs SOM →EYE vs SPL →
EYE Full Analysis → LDX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).